oncology research
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
oncology research
Oct 17, 2024, 17:25 |
Blog
Ashwin Kishtagari: A fantastic visit to Cleveland Clinic Translational Hematology and Oncology Research program
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared a post on X: ''Had a…
Sep 14, 2024, 06:29 |
Blog
Zheng Wang: Excited to share our concepts of precision medicine and novel research in breast cancer at the Global Summit
Zheng Wang, Clinical Assistant Professor at Ruijin Hospital Affiliated to Shanghai Jiao Tong University, posted the…
Sep 13, 2024, 19:19 |
Blog
Advances in cancer care must consider the impact on patients’ reproductive health - ASCO
ASCO - American Society of Clinical Oncology made the following post on LinkedIn: “Advances in cancer care…
Sep 10, 2024, 13:52 |
Career
Antonio Giordano: Excited to welcome Dr. Benjamin Ebert as next CEO of Dana Farber Cancer Institute
Antonio Giordano, President of Sbarro Health Research Organization, shared a post by The Boston Globe,…
Sep 10, 2024, 10:38 |
Blog
Vivek Subbiah: Precision Dosing IS Precision Oncology
Vivek Subbiah shared a post on X: “Pleased to share the pre-proof version of the…
Sep 7, 2024, 08:36 |
Blog
Jasmin Hundal: Less than three weeks until COSMO
COSMO is an annual conference focused on medical and healthcare topics. This forum typically gathers…
Aug 29, 2024, 03:06 |
Blog
Mark Lewis: We’re accepting submissions for JCO Oncology Advances
Mark Lewis shared on X: "Calling all oncology researchers! We’re accepting submissions for JCO Oncology…
Aug 26, 2024, 21:39 |
Blog
Article of the day suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute made the following post on LinkedIn: "Article of the day suggested…
Aug 10, 2024, 07:29 |
Insight
Emiliano Calvo Aller on ‘Pharmacology and Dose-Selection of ADCs’ at the ESMO2024 Oral Abstract Session
The START Center for Cancer Care shared on LinkedIn: “Join START at the ESMO2024 Oral…
Aug 6, 2024, 11:02 |
Blog
Elizabeth McKenna: The August issue of Cancer Discovery is now online
Elizabeth McKenna shared a post on X: "The August issue of Cancer Discovery is now online!…
Aug 6, 2024, 01:55 |
Blog
ctDNA's evolving role in cancer treatment
Yüksel Ürün shared on X: “The NCI Workshop highlighted ctDNA's evolving role in cancer treatment.…
Aug 3, 2024, 00:00 |
Positive
Chong-xian Pan received VA grant to establish GU precision Oncology network
Chong-xian Pan, Associate Professor Of Medicine at Brigham and Women's Hospital, shared a post on…
Aug 2, 2024, 14:10 |
Blog
Wafik S. El-Deiry: Gen X and millennials at higher cancer risk than older generations
Wafik S. El-Deiry shared a post on X: "Gen X and millennials at higher cancer…
Aug 2, 2024, 14:00 |
Insight
Alessandro Santin: This is a major 'bench-to-bedside' accomplishment for uterine cancer patients
Yale Cancer Center made the following post on X: "Led by Dr. Alessandro Santin and researchers…
Aug 2, 2024, 13:54 |
Blog
University of Cambridge With Cambridge University Hospitals NHS Is Building Cambridge Cancer Research Hospital
Cambridge University made the following post on X: "Imagine a future where no one dies from…
Aug 2, 2024, 00:52 |
Blog
$RAC announces conclusion of an investigator-sponsored trial of bisantrene - Race Oncology
Race Oncology made the following post on X: "$RAC is pleased to announce the successful…
Jul 12, 2024, 23:55 |
Blog
Cathrin Brisken: Carlos Ronchi overcame an important hurdle in breast cancer genomics
Cathrin Brisken, Professor at The Institute of Cancer Research, made the following post on X:…
Jul 9, 2024, 07:06 |
Blog
LARVOL At The Annual Clinical Trials in Oncology East Coast 2024
LARVOL made the following post on X: "The Annual Clinical Trials in Oncology East Coast…
Jul 8, 2024, 11:44 |
Blog
The role of adjuvant chemotherapy and chemoradiation in Gallbladder cancers
Hepatobiliary and Retroperitoneal Sarcoma Division of Surgical Oncology at Tata Memorial Cancer Hospital made the following…
Jul 7, 2024, 15:49 |
Blog
Kelly Norsworthy: Submit your Pragmatic Trials ideas to FDA Oncology
Kelly Norsworthy, Deputy Division Director, Division of Hematologic Malignancies 1 at Johns Hopkins University, shared…
Jul 7, 2024, 15:44 |
Blog
Francesco Cortiula: What evidences for the treatment of patients with stage III NSCLC excluded from trials?
Francesco Cortiula, Medical Oncologist at University Hospital of Udine, made the following post on X:…
Jul 4, 2024, 13:06 |
Blog
Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh
Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X: “The NTACT residual disease test,…
Jul 4, 2024, 09:04 |
Insight
Esranur Aydın: A remarkable success in treating a heavily pretreated metastatic CRC patient
Esranur Aydın, Clinical Cancer Molecular Biologist at Medicana Health Group, shared on LinkedIn: "Publication Allert…
Jul 3, 2024, 08:52 |
Insight
Paolo Tarantino: More data supporting that ADCs act in part by extending the half life of payloads
Paolo Tarantino shared a post by Raffaele Colombo on X, adding the following: “More data…
Jul 3, 2024, 02:35 |
Insight
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Absolutely abscopal…
Jul 2, 2024, 14:57 |
Blog
Wafik S. El-Deiry: My second talk at the DAVA Oncology 3rd Global Thoracic Malignancies Summit
Wafik S. El-Deiry shared on LinkedIn: “Gave my second talk at the DAVA Oncology 3rd…
Jul 2, 2024, 08:18 |
Blog
Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis
Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…
Jul 1, 2024, 17:38 |
Blog
Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients
Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post…
Jul 1, 2024, 17:27 |
Blog
Bernard A. Fox: A new generation of immunotherapy clinical trials
Bernard A. Fox, Co-Founder and CEO of UbiVac shared on LinkedIn: “Great to be in…
Jul 1, 2024, 17:09 |
Blog
Patrick Hwu: ctDNA testing, cancer screening and treatment
Patrick Hwu shared a post LinkedIn: “How are we using ctDNA testing, also called liquid…
Jul 1, 2024, 15:01 |
Blog
Antonio Passaro: A significant milestone for the advancement and understanding of EGFR-mutated NSCLC
Antonio Passaro, shared a post on LinkedIn: "I am honored to have contributed, as investigator…
Jul 1, 2024, 11:57 |
Insight
START Midwest team has successfully dosed the first patient in the first QTX3046 Phase I trial
The START Center for Cancer Research shared on LinkedIn: "We are proud to announce that…
Jul 1, 2024, 11:45 |
Blog
Susanna F. Greer: Fifteen Women scientists awarded more than 10M in research grants from the V Foundation
Susanna F. Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared a…
Jul 1, 2024, 02:17 |
Opinion
Michael Wang: Excellent review of the actions and complex regulation of p53
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jun 30, 2024, 04:26 |
Blog
Julia Lai-Kwon: Delphi study on alert thresholds and self management advice for immunotherapy at MASCC24
Julia Lai-Kwon, Medical Oncologist and PhD candidate at Peter Mac Cancer Centre, recently shared a…
Jun 28, 2024, 12:02 |
Blog
Herbert Loong: Regulatory Harmonisation For Oncology Clinical Trials in the APAC Region
Herbert Loong made the following post on LinkedIn: . "A shoutout again to all colleagues…
Jun 28, 2024, 01:53 |
Blog
Julia Lai-Kwon: Hope Rugo highlighting the different toxicities between different ADCs
Julia Lai-Kwon, Medical Oncologist and PhD candidate at Peter Mac Cancer Centre, recently shared a…
Jun 24, 2024, 22:56 |
Blog
Giovanni Marchegiani: Perioperative modified FOLFIRINOX for pancreas cancer
Giovanni Marchegiani, Pancreas Surgeon at The University of Padua, made the following post on X:…
Jun 24, 2024, 13:33 |
Blog
Erika Hamilton's insights into the future of ADCs in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn: “We are thrilled to share…
Jun 18, 2024, 02:22 |
Blog
Mohammad Jad Moussa: Kidney Cancer Education Event ‘24
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…
Jun 15, 2024, 14:32 |
Blog
Maite Gorostegui: Journal Clubs Are Key For Any Fellowship Program
Maite Gorostegui, Chair of the SIOP Global Mapping Programme, shared a post on LinkedIn: “Do…
Jun 15, 2024, 09:25 |
Blog
Gertjan Rasschaert: Botbal in refractory pMMR/MSS mCRC: a phase 1 trial by Andrea J. Bullock et al.
Gertjan Rasschaert, Medical Doctor, Consultant Gastrointestinal Oncology and Gastroenterology at UZ Leuven, shared a post on LinkedIn:…
Jun 14, 2024, 13:17 |
Blog
We are still catching our breath from ASCO24 - Realyze Intelligence
Realyze Intelligence shared on LinkedIn: " What. An. ASCO24. It's been a week and we…
Jun 13, 2024, 09:39 |
Blog
Aparna Kesarwala has been named a 2024 Gilead Research Scholar - Winship Cancer Institute of Emory University
Winship Cancer Institute of Emory University announced on X: . “Winship researcher Aparna Kesarwala,…
Jun 13, 2024, 04:21 |
Blog
Runcie C.W. Chidebe: Happy to see Zainab Shinkafi-Bagudu driving cancer patient advocacy conversations
Runcie C.W. Chidebe shared a post by ecancer on X, adding the following: “Diverse and inclusive…
Jun 10, 2024, 15:00 |
Blog
Sumanta K. Pal: PIVOT09 comparing pegylated IL2/nivolumab to TKI by Nizar Tannir et al.
Sumanta K. Pal shared a post on X: “Huge congrats to Nizar Tannir, MD Anderson Cancer…
Jun 10, 2024, 10:31 |
Opinion
Armando Orlandi: To explain the unexplainable in MONARCH 3
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, made the following post on X:…
Jun 10, 2024, 07:25 |
Blog
The phase III NETTER-2 trial published in The Lancet and presented by Pamela Kunz at ASCO24 - Yale Cancer Center
Yale Cancer Center shared a post on X: “The phase III NETTER-2 trial published in The…
Jun 10, 2024, 07:05 |
Blog
Billy Rosa: Thrilled to see our paper on palliative care and cancer pain with coexisting aberrant behaviors
Billy Rosa, Assistant Attending Behavioral Scientist at MSK Cancer Center, posted on X: “Thrilled to…
Jun 10, 2024, 06:31 |
Blog
Michelle Janisch: Breast Cancer Index team presented data at ASCO24
Michelle Janisch, VP Marketing and Strategic Alliances at Hologic Inc., made the following post on…
Jun 10, 2024, 06:14 |
Blog
Myriam Chalabi: Happy moment with Christian Blank
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 10, 2024, 06:00 |
Blog
Pam Mangat-Dhaliwal: Powerful women at work!
Pam Mangat-Dhaliwal, Division Director of Clinical Research and Analytics at ASCO, shared a post on…
Jun 10, 2024, 04:49 |
Blog
Ibrahim Halil Sahin: I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski
Ibrahim Halil Sahin Assistant Professor of Medicine Division of Hematology/Oncology at University of Pittsburgh School of…
May 31, 2024, 18:51 |
Blog
Sameh Abdelmalak: Dr. Sara Tolaney and Dr. Hope Rugo discussing ASCO24 Noteworthy Abstracts in Breast Cancer
Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, made the following post on X: "Check…
May 30, 2024, 02:01 |
Blog
Wei Zhang: P21 and cancer
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 28, 2024, 14:05 |
Blog
Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…
May 28, 2024, 05:55 |
Blog
Why does Dr. Diaz focus his research on older Hispanic and Latino patients with cancer? - Conquer Cancer, the ASCO Foundation
Conquer Cancer, the ASCO Foundation shared a post on LinkedIn: “Why does Dr. Diaz focus his…
May 25, 2024, 12:37 |
Blog
Neeraj Agarwal: Camrelizumab+apatinib in previously treated pts w/ advanced adrenocortical cancer by Zhigong Wei
Neeraj Agarwal shared a post on X: “Ab#4511 ASCO ASCO 24 by Zhigong Wei. Camrelizumab+apatinib ph2…
May 24, 2024, 14:32 |
Blog
Tarita Thomas: Northwestern Medicine taking over Capitol Hill for ASTRO Advocacy Day!
Tarita Thomas, Associate Professor at Northwestern University Feinberg School of Medicine, shared the following post…
May 24, 2024, 13:24 |
Insight
Erman Akkus Summarizes 5-year Results of CheckMate 040
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Nivolumab plus ipilimumab…
May 23, 2024, 12:31 |
Blog
Join four top experts to discuss Post-AACR Spatial Biology Trench and Decoding Cancer Insights - Akoya Biosciences
Akoya Biosciences shared a post on LinkedIn: “How is spatial biology influencing the trajectory of…
May 23, 2024, 09:20 |
Blog
Yakup Ergün Summarizes Final Results of RIGHT Choice
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on X:…
May 23, 2024, 07:56 |
Blog
Chinmay Jani: Let's explore EGFR Exon 20 Insertion NSCLC with a twist of Miami flair!
Chinmay Jani, Clinical Fellow, Hematology & Oncology at University of Miami, made the following post…
May 23, 2024, 07:39 |
Blog
Daniel Sterman: Congratulations Antonio Velez, on his superb presentation of our NCI-funded clinical trial
Daniel Sterman, Director of Division of Pulmonary, Critical Care, and Sleep Medicine at NYU Langone Health, made…
May 21, 2024, 13:26 |
Blog
A collaborative network of leading myeloma treatment centers that conduct early-stage clinical trials - Multiple Myeloma Research Foundation
Multiple Myeloma Research Foundation, made the following post on X: “The MMRC® is a collaborative…
May 21, 2024, 13:21 |
Blog
Drew Moghanaki: The VA is studying how to expand lung cancer screening eligibility criteria
Drew Moghanaki shared on X: “The VA is studying how to expand lung cancer screening eligibility…
May 21, 2024, 12:56 |
Blog
Miguel Regueiro: Sarah Wehbé presenting a new scoring system that predicts young onset colon cancer
Jame Abraham, Chairman of the Department & Professor of Hematology and Medical Oncology at Cleveland Clinic,…
May 21, 2024, 12:32 |
Blog
Petros Grivas: Timely paper on the expression and molecular correlates of therapy targets in prostate cancer
Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of Washington…
May 21, 2024, 12:00 |
Blog
Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
May 20, 2024, 14:44 |
Blog
Syed A. Ahmad: Our review on neoadjuvant and adjuvant therapy for resectable pancreas cancer
Syed A. Ahmad, Director at University of Cincinnati Cancer Center & Chief of Surgical Oncology…
May 20, 2024, 14:23 |
Insight
Yüksel Ürün: Does oncologic treatment for very advanced disease improve survival?
Yüksel Ürün shared a post on X: “Does oncologic treatment for very advanced disease improve survival?…
May 20, 2024, 13:46 |
Blog
Jakob Nikolas Kather: GPT-4 API to answer medical oncology questions based on guidelines
Jakob Nikolas Kather, Professor of Clinical Artificial Intelligence at Dresden University of Technology, made the…
May 19, 2024, 10:12 |
Insight
Erman Akkus: Is oncologic treatment of very advanced disease associated with improved survival?
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X: “Is oncologic treatment…
May 18, 2024, 11:16 |
Blog
Paolo Tarantino: Important point by Erika Hamilton - common questions should derive from RCTs
Paolo Tarantino shared the following post by ESMO on X, adding the following: "Important point…
May 18, 2024, 08:38 |
Opinion
New Insights to Tackle Sexual Impairment in BC - ESMO
The European Society for Medical Oncology (ESMO) shared on X: “ESMO Breast 24: Two studies on…
May 18, 2024, 08:31 |
Opinion
Guillermo Villacampa: Marleen Kok presents the ESMO Breast 24 key message in translation research
Paolo Tarantino shared the following post by Guillermo Villacampa, Biostatistician in the Oncology Data Science…
May 16, 2024, 12:46 |
Blog
Wafik S. El-Deiry: Exciting Brown University Oncology Research Group Updates
Wafik S. El-Deiry posted on X: “Exciting Brown University Oncology Research Group updates at The…
May 15, 2024, 09:03 |
Blog
Stephanie Graff: Honored to join Wolfgang Janni and Carlos Barrios at ESMO Breast 24
Stephanie Graff shared a post on X: “Leaving soon for ESMO Breast 24. Honored to…
May 14, 2024, 09:19 |
Blog
Vivek Subbiah: Picking that needle in haystack --> ROS1 fusion in Glioblastoma
Quoting Vivek Subbiah on X: “Picking that needle in haystack --> ROS1 fusion in Glioblastoma. Striking response…
May 13, 2024, 14:19 |
Insight
Javier Retamales: Our latest manuscript about building capacity and fostering sustainable improvements in cancer care
Javier Retamales, Executive Director at GOCCHI, shared on LinkedIn: "I am thrilled to share that…
May 12, 2024, 13:47 |
Blog
Peter Pisters: Thrilled to join our MD Anderson Cancer Center's Brain Metastasis Research Retreat
Peter Pisters, President of The University of Texas MD Anderson Cancer Center, shared on X/Twitter:…
May 11, 2024, 12:13 |
Insight
Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: "Comprehensive mutational scanning of EGFR…
May 10, 2024, 14:28 |
Blog
Amil Družić : Clinic of Oncology at the Clinical center University of Sarajevo became part of the IWWD
Amil Družić, Oncology and Radiotherapy Resident at the Clinical Center University of Sarajevo, posted on LinkedIn:…
May 3, 2024, 00:05 |
Blog
Jeremy Teoh: ERBT could reduce the 1-year recurrence rate in NMIBC
Jeremy Teoh, Assistant Dean (External Affairs) & Associate Professor at CUHK Medicine, made the following…
May 2, 2024, 23:03 |
Career
Steven Kridel: I’m starting a new position as Chair of Department of Cancer Biology at Wake Forest University School of Medicine!
Steven Kridel, Chair, Department of Cancer Biology at Wake Forest University School of Medicine, made…
May 1, 2024, 20:07 |
Blog
Vivek Subbiah: Looking forward to delivering the keynote at the esteemed PRISM center in Paris
Vivek Subbiah shared a post on LinkedIn: “Just landed in Paris! Looking forward to delivering…
Apr 30, 2024, 19:43 |
Insight
Erman Akkus: Our new study Prostate Cancer and PARPi
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X: “Our…
Apr 29, 2024, 20:33 |
Blog
Don't miss the TAPUR Study Virtual Grand Rounds on May 6 - American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO) shared on LinkedIn: “"Don't miss the TAPUR Study Virtual Grand…
Apr 29, 2024, 20:00 |
Opinion
Erika Hamilton: Really feel like we don't need to be testing for HER-2 for TDXd in breast cancer
Erika Hamilton shared a post by Giuseppe Curigliano, Chief of the Clinical Division of Early…
Apr 27, 2024, 14:10 |
Opinion
Youth Cancer Europe's Fully reimbursed Training on Equitable, Inclusive, and Diverse Cancer Care taking place between 3 - 6 June in Cluj-Napoca, Romania!
Youth Cancer Europe shared on LinkedIn: "If you are a researcher or a professional with academic…
Apr 22, 2024, 14:45 |
Blog
Sylvester Comprehensive Cancer Center - the 2nd Biennial Miami Precision Medicine Conference focused on unraveling the DNA code
An event by Sylvester Comprehensive Cancer Center on May 4-5, sponsored by the University of…
Feb 29, 2024, 05:24 |
Insight
Fadila Kouhen: Thrilled to have published my insights on concomitant immunotherapy and radiotherapy in cervical cancer
Fadila Kouhen, Associate Professor at Cheikh Khalifa International University Hospital, shared on LinkedIn: "Thrilled to…
Aug 18, 2023, 04:56 |
Insight
Nicola Fusco: The assessment of PDL1 Combined Positive Score (CPS)≥10 in metastatic triple-negative breast cancer.
Nicola Fusco, an Associate Professor at the Department of Oncology and Hemato-Oncology at the University…
All:
93
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube